Merit Medical Systems News

Merit Medical Reports Record Sales, Up 10%, for the Quarter Ended March 31, 2012

Tue, 24 Apr 2012 20:02:00 +0000

SOUTH JORDAN, Utah, Apr 24, 2012 (GlobeNewswire via COMTEX) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced record sales of $95.6 million for the quarter ended March 31, 2012, an increase of 10.4% over sales of $86.6 million for the quarter ended March 31, 2011. Merit's non-GAAP net income for the quarter ended March 31, 2012, adjusted to eliminate non-recurring costs attributable primarily to Merit's acquisition of Ostial Solutions, LLC and the Clo-SurPLUS P.A.D.(TM) as well as amortization of intangible assets, was $7.2 million, or $0.17 per share, co...

Merit Medical Systems to Announce First Quarter 2012 Results on April 24, 2012

Wed, 11 Apr 2012 13:31:06 +0000

SOUTH JORDAN, Utah, April 11, 2012 /PRNewswire/ -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2012, after the close of the stock market on Tuesday, April 24th, 2012. Merit will hold its investor conference call on the same day (Tuesday, April 24th, 2012) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). The telephone numbers to call are (domestic) 888-549-7750; and (international) 480-629-9770. A live webcast will als...

Merit Medical Announces 510(k) Clearance for 30-60um QuadraSphere(R) Microspheres

Mon, 26 Mar 2012 13:30:00 +0000

SOUTH JORDAN, Utah, March 26, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 510(k) clearance from the FDA for the newly developed 30-60um QuadraSphere® Microspheres. When packaged in their dry state, the new microspheres measure 30-60um, but when reconstituted for use, they expand to 120-240um. "This product is an important addition to our embolic portfolio and will be featured at the Society of Interventional Radiology (SIR) meeting this week in San Francisco," said Fred P. Lampropoulos, Merit's Chairman and...

Merit Medical to Participate at Sidoti & Company's Emerging Growth Institutional Investor Forum

Wed, 14 Mar 2012 13:30:00 +0000

SOUTH JORDAN, Utah, March 14, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Sidoti & Company's Sixteenth Annual Emerging Growth Institutional Investor Forum being held March 19-20, 2012 at The Grand Hyatt New York. On Tuesday, March 20th, at 9:20 a.m. ET, Merit's Chief Financial Officer Kent W. Stanger will give a 30-minute presentation regarding Merit's history, products, financial performance and prospects. He will also participate in one-on-one meetings throughout the day. ABOUT MERIT Fou...

Merit Medical to Participate at Raymond James Institutional Investors Conference

Mon, 27 Feb 2012 14:30:00 +0000

SOUTH JORDAN, Utah, Feb. 27, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Raymond James 33rd Annual Institutional Investors Conference being held March 4-7, 2012 at the JW Marriott Grande Lakes in Orlando. On Wednesday, March 7th, at 9:50 a.m. ET, Merit's Chief Financial Officer Kent W. Stanger will give a 30-minute presentation regarding Merit's history, products, financial performance and prospects. A live webcast of his presentation will be available at http://www.wsw.com/webcast/rj72/mmsi/ and arch...

Merit Medical Reports Record Sales and Net Income for the Year Ended December 31, 2011 and Gives Sales and Earnings Guidance for 2012

Thu, 23 Feb 2012 21:00:00 +0000

Revenues Up 21% for the Year and 12% for the Quarter Gross Margins Up 270 Basis Points for the Year and 150 Basis Points for the Quarter SOUTH JORDAN, Utah, Feb. 23, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced revenues of $91.1 million for the quarter ended December 31, 2011, an increase of 12% over revenues of $81.2 million for the quarter ended December 31, 2010. Revenues for the year ended December 31, 2011 were a record $359.4 million, an increase of 21% over revenues of $296.8 million for the year ended December 31, 2010. ...

Merit Medical to Present at RBC and Lazard Conferences

Wed, 22 Feb 2012 14:30:00 +0000

SOUTH JORDAN, Utah, Feb. 22, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two upcoming investor conferences. On Tuesday, February 28th, at 11:30 a.m. ET, Merit's Chairman and Chief Executive Officer Fred P. Lampropoulos will present at RBC Capital Markets' Healthcare Conference at The New York Palace Hotel in New York City. He will also participate in one-on-one meetings throughout the day. A live webcast of the presentation will be available at http://www.wsw.com/webcast/rbc141/mmsi/ and will be archi...

Merit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate(R) Hydrophilic Guidewire

Tue, 07 Feb 2012 19:45:00 +0000

SOUTH JORDAN, Utah, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding modifications to the hydrophilic coating process for the Merit Laureate® Hydrophilic Guidewire after an inspection of the Company's facility in Galway, Ireland. "Merit takes very seriously its commitment to quality and compliance to applicable regulations, and we intend to work cooperatively with the FDA to resolve the issues in the warning letter," said Fred P. Lampropou...

Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 23, 2012

Tue, 07 Feb 2012 14:30:00 +0000

SOUTH JORDAN, Utah, Feb. 7, 2012 /PRNewswire/ -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2011, after the close of the stock market on Thursday, February 23rd, 2012. Merit will hold its investor conference call on the same day (Thursday, February 23rd, 2012) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). The telephone numbers to call are (domestic) 877-941-2332; and (international) 480-629-9723. A liv...

Merit Medical Announces the Purchase of the Assets of Ostial Solutions, LLC

Wed, 01 Feb 2012 14:30:00 +0000

SOUTH JORDAN, Utah, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Ostial Solutions, LLC, a privately-held company based in Kalamazoo, Michigan, under terms which require approximately 33% of the anticipated purchase price to be paid at closing, approximately 22% of the anticipated purchase price to be paid within six months of closing and the balance to be paid only upon achievement of negotiated earn-out objectives. The primary asset of Ostial Solutions is the patented Ostial Pro Stent P...